Neuraxis
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neuraxis and other ETFs, options, and stocks.About NRXS
NeurAxis, Inc. engages in the provision of neuromodulation therapies to address chronic and debilitating conditions in children. Its product, IB-Stim, is a non-surgical device that works by sending gentle electrical impulses into cranial nerve bundles located in the ear.
CEOBrian Carrico
CEOBrian Carrico
Employees21
Employees21
HeadquartersCarmel, Indiana
HeadquartersCarmel, Indiana
Founded2011
Founded2011
Employees21
Employees21
NRXS Key Statistics
Market cap49.70M
Market cap49.70M
Price-Earnings ratio-4.81
Price-Earnings ratio-4.81
Dividend yield—
Dividend yield—
Average volume181.55K
Average volume181.55K
High today$4.89
High today$4.89
Low today$4.61
Low today$4.61
Open price$4.78
Open price$4.78
Volume84.76K
Volume84.76K
52 Week high$6.20
52 Week high$6.20
52 Week low$1.33
52 Week low$1.33
Stock Snapshot
Neuraxis(NRXS) stock is priced at $4.69, giving the company a market capitalization of 49.7M. It carries a P/E multiple of -4.81.
On 2026-01-14, Neuraxis(NRXS) stock traded between a low of $4.61 and a high of $4.89. Shares are currently priced at $4.69, which is +1.7% above the low and -4.1% below the high.
Neuraxis(NRXS) shares are trading with a volume of 84.76K, against a daily average of 181.55K.
In the last year, Neuraxis(NRXS) shares hit a 52-week high of $6.20 and a 52-week low of $1.33.
In the last year, Neuraxis(NRXS) shares hit a 52-week high of $6.20 and a 52-week low of $1.33.
People also own
Based on the portfolios of people who own NRXS. This list is generated using Robinhood data, and it’s not a recommendation.